Consolidated Statements of Financial Position - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash	$ 3,323,708	$ 1,623,957
Restricted cash (note 13)	1,000,000	1,000,000
Accounts receivable, net (note 20(b))	7,569,843	7,348,846
Prepaid expenses and other	3,079,785	2,520,676
Total current assets	14,973,336	12,493,479
Property, plant and equipment (note 6)	4,793,979	3,719,621
Intangible assets (note 7)	622,057	688,249
Goodwill	0
Finance right-of-use assets (note 8(a))	2,140,338	19,348,091
Operating right-of-use assets (note 8(b))	28,887,905	34,890,554
Total assets	51,417,615	71,139,994
Current liabilities:
Accounts payable and accrued liabilities (note 9)	13,701,630	20,271,624
Current portion of loans payable (note 10(a))	5,770,603	2,200,892
Current portion of finance lease liabilities (note 8(a))	622,730	6,532,175
Current portion of operating lease liabilities (note 8(b))	3,960,346	4,591,216
Current portion of shareholder loan (note 11)	505,161	46,995
Other payables (note 12)	5,730,781	629,381
Non-controlling interest loans (note 10(b))	63,174	94,136
Deferred and contingent consideration (note 13)	1,000,000	1,000,000
Advance for research collaboration (note 14)	1,300,000
Total current liabilities	32,654,425	35,366,419
Loans payable (note 10(a))	90,230,173	51,017,743
Finance lease liabilities (note 8(a))	235,107	10,449,725
Operating lease liabilities (note 8(b))	26,438,220	31,352,506
Shareholder loan (note 11)	2,807,480	2,065,443
Total liabilities	152,365,405	130,251,836
Shareholders' deficit:
Common shares (note 15)	120,741,061	114,120,362
Contributed surplus (note 16)	5,397,700	4,552,067
Deficit	(224,174,970)	(175,007,144)
Total shareholders' deficit excluding non-controlling interest	(98,036,209)	(56,334,715)
Non-controlling interest (note 24)	(2,911,581)	(2,777,127)
Total shareholders' deficit	(100,947,790)	(59,111,842)
Contingencies (note 17)
Total liabilities and shareholders' deficit	$ 51,417,615	$ 71,139,994